1 news.
Journal editor disputes Vioxx maker's claim 
NEW YORK -- The New England Journal of Medicine demanded changes before publishing results of the study that led Merck and Co. to pull the painkiller Vioxx from the market, and one of its top editors disputes the way the drug maker is using it as a pillar of its legal defense in liability suits.Boston Globe -- Business News, Fri, 10 Feb 2006 13:25:35 +0100
NEW YORK -- The New England Journal of Medicine demanded changes before publishing results of the study that led Merck and Co. to pull the painkiller Vioxx from the market, and one of its top editors disputes the way the drug maker is using it as a pillar of its legal defense in liability suits.Boston Globe -- Business News, Fri, 10 Feb 2006 13:25:35 +0100